Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells泽伦尼stat介导的药理豆蔻酰化抑制破坏了三阴性乳腺癌细胞的生长信号、能量代谢和迁移Breast Cancer-Targets and TherapyIF3.42026-09-300OAAI
Zelenirstat Inhibits N-Myristoyltransferases to Disrupt Src Family Kinase Signaling and Oxidative Phosphorylation, Killing Acute Myeloid Leukemia CellsMOLECULAR CANCER THERAPEUTICSIF5.52024-10-090OAAI
Multiomics analysis identifies oxidative phosphorylation as a cancer vulnerability arising from myristoylation inhibitionJOURNAL OF TRANSLATIONAL MEDICINEIF7.52024-05-074OAAI
N-myristoylation inhibitor zelenirstat: New mechanistic insights and efficacy signals from a first in human phase I studyCANCER RESEARCHIF16.62024-04-050PRE
Understanding the sensitivity of cancer cells to myristoylation inhibitors for oncology applicationsCANCER RESEARCHIF16.62023-04-040PRE
N-myristoylation inhibition reduces angiogenesis and cancer cell migrationCANCER RESEARCHIF16.62023-04-041PRE